Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Am Anim Hosp Assoc ; 55(4): e55405, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31099603

RESUMO

A 10 yr old castrated male pug was presented with a 3 day history of intermittent dyspnea, cough, inappetence, and inability to breathe while sleeping. He had previously received hypofractionated radiation therapy for an amelanotic oral malignant melanoma (OMM) 7 mo prior to presentation. At presentation, the dog was gasping and dyspneic. Oral examination identified the OMM on the right hard palate. Thoracic radiographs revealed an angular soft-tissue opacity within the trachea just distal to the thoracic inlet. No evidence of pulmonary metastatic disease was seen. Tracheoscopy identified a pedunculated, nonpigmented mass within the lumen of the distal trachea near the carina. Treatment options were presented to the owners and included tracheal stenting or tracheal resection and anastomosis. Because of the poor prognosis, the owners elected humane euthanasia. Postmortem examination confirmed the presence of melanoma in the distal trachea; no other sites of OMM metastasis were identified. The cause of OMM development in the distal trachea in this case is suspected to have resulted from mechanical tumor cell seeding during endotracheal tube placement for general anesthesia 7 mo prior to presentation. Despite the reported rarity of mechanical tumor seeding, this potential complication warrants consideration in dogs with OMM.


Assuntos
Doenças do Cão/patologia , Doença Iatrogênica/veterinária , Intubação Intratraqueal/veterinária , Melanoma/veterinária , Neoplasias Bucais/veterinária , Inoculação de Neoplasia , Animais , Cães , Intubação Intratraqueal/efeitos adversos , Masculino , Melanoma/patologia , Neoplasias Bucais/patologia
2.
J Public Health Manag Pract ; 24 Suppl 3: S92-S94, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29595610

RESUMO

The Florida Department of Health (Department) received accreditation status as an integrated public health system from the Public Health Accreditation Board (PHAB) in 2 phases: the State Health Office received accreditation in June 2014 and the 67 county health departments received accreditation in March 2016. Six weeks after PHAB awarded accreditation to the Department as an integrated public health system in March 2016, the World Health Organization declared the Zika outbreak in the Americas a Public Health Emergency of International Concern. Even in that short time, integrated public health accreditation, along with the other components of the Department's performance management system, allowed the Department to address this public health emergency, especially in Miami-Dade County, where the impact of Zika was significant. This case report describes the local response in Miami-Dade County and supporting statewide efforts. Public health departments should consider how public health accreditation could strengthen their ability to fulfill their public health mission. This article provides rationale for state and local health departments to seek accreditation.


Assuntos
Acreditação/normas , Resiliência Psicológica , Infecção por Zika virus/psicologia , Acreditação/organização & administração , Surtos de Doenças/prevenção & controle , Surtos de Doenças/estatística & dados numéricos , Florida , Humanos , Prática de Saúde Pública , Zika virus/patogenicidade , Infecção por Zika virus/prevenção & controle
3.
J Am Anim Hosp Assoc ; 54(6): e54604, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30272485

RESUMO

Hypercalcemia is a biochemical abnormality that, when left untreated, can lead to life-threatening complications including renal failure. Bisphosphonates are routinely used to treat hypercalcemia, but most literature on veterinary patients describes the use of pamidronate. This retrospective case series describes the use of zoledronate for treatment of hypercalcemia in four dogs. Information including signalment, clinical signs, treatment, and outcome was collected. All dogs showed a decrease in total and ionized calcium concentrations after treatment with zoledronate. All treatments of zoledronate administered were well tolerated, but a previously unreported local hypersensitivity reaction was observed in one dog. This report is the first to document the efficacy of zoledronate for treatment of hypercalcemia in dogs.


Assuntos
Doenças do Cão/tratamento farmacológico , Hipercalcemia/veterinária , Ácido Zoledrônico/uso terapêutico , Animais , Conservadores da Densidade Óssea/uso terapêutico , Cálcio/sangue , Cães , Hipercalcemia/tratamento farmacológico , Estudos Retrospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA